Replimune (REPL) Change in Accured Expenses (2017 - 2026)

Replimune (REPL) has 10 years of Change in Accured Expenses data on file, last reported at $6.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 25.74% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 81.4% YoY), and the FY2026 full-year result was $2.2 million, down 81.4% from the prior year.
• Change in Accured Expenses advanced to $6.9 million in Q1 2026, from -$1.9 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $9.2 million in Q1 2025 to a low of -$5.5 million in Q2 2025.
• A 5-year average of $2.2 million and a median of $2.8 million in 2025 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses tumbled 333.99% in 2022 and jumped 715.46% in 2024, its largest moves.
• Tracing REPL's Change in Accured Expenses over 5 years: stood at $2.8 million in 2022, then tumbled by 130.01% to -$854000.0 in 2023, then surged by 715.46% to $5.3 million in 2024, then plunged by 136.4% to -$1.9 million in 2025, then surged by 458.76% to $6.9 million in 2026.
• Business Quant data shows REPL's Change in Accured Expenses at $6.9 million in Q1 2026, -$1.9 million in Q4 2025, and $2.8 million in Q3 2025.